Cliona Kirwan

6.5k total citations
94 papers, 1.6k citations indexed

About

Cliona Kirwan is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Cliona Kirwan has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 40 papers in Cancer Research and 27 papers in Surgery. Recurrent topics in Cliona Kirwan's work include Breast Cancer Treatment Studies (31 papers), Breast Implant and Reconstruction (23 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Cliona Kirwan is often cited by papers focused on Breast Cancer Treatment Studies (31 papers), Breast Implant and Reconstruction (23 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Cliona Kirwan collaborates with scholars based in United Kingdom, United States and Sweden. Cliona Kirwan's co-authors include Ged Byrne, Garry McDowell, Charles McCollum, Richard K. Johnson, John Murphy, Lyndsey Highton, Judith M. Bliss, Alex J Walker, James Harvey and Matthew J. Grainge and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Cliona Kirwan

91 papers receiving 1.6k citations

Peers

Countries citing papers authored by Cliona Kirwan

Since Specialization

Citations

This map shows the geographic impact of Cliona Kirwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cliona Kirwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cliona Kirwan more than expected).

Fields of papers citing papers by Cliona Kirwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cliona Kirwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cliona Kirwan. The network helps show where Cliona Kirwan may publish in the future.

Co-authorship network of co-authors of Cliona Kirwan

This figure shows the co-authorship network connecting the top 25 collaborators of Cliona Kirwan. A scholar is included among the top collaborators of Cliona Kirwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cliona Kirwan. Cliona Kirwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial 2025 ·Radiotherapy and Oncology ·(unknown), Lucy Kilburn, Anna M. Kirby, Clare Griffin, Mark Sydenham, Cliona Kirwan, Joanne Haviland, Indrani Bhattacharya, Monica Jefford, Isabel Syndikus, Judith M. Bliss, Charlotte E. Coles	1
2	Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials 2025 ·Radiotherapy and Oncology ·(unknown), Anna M. Kirby, Lucy Kilburn, Clare Griffin, Mark Sydenham, (unknown), Cliona Kirwan, Monica Jefford, Isabel Syndikus, Judith M. Bliss, Charlotte E. Coles	0
3	Age and sex can predict cancer risk in people referred with breast symptoms 2023 ·BMJ ·Toral Gathani, Ramsey Cutress, David Dodwell, Kieran Horgan, Cliona Kirwan, Hilary Stobart, Sau Wan Kan, Gillian Reeves, Siân Sweetland	6
4	The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer 2023 ·Cancer Medicine ·(unknown), (unknown), (unknown), Rebecca Lamb, (unknown), Sarah Duff, Cliona Kirwan	5
5	Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study 2022 ·The Breast ·Anthony Maxwell, Bridget Hilton, Karen Clements, David Dodwell, (unknown), Olive Kearins, Cliona Kirwan, Janet Litherland, Senthurun Mylvaganam, Elena Provenzano, Sarah E. Pinder, Elinor J. Sawyer, Abeer M. Shaaban, Nisha Sharma, Hilary Stobart, Matthew Wallis, Alastair M. Thompson	21
6	Results of shared learning of a new magnetic seed localisation device – A UK iBRA-NET breast cancer localisation study 2022 ·European Journal of Surgical Oncology ·Jenna Morgan, (unknown), Rajiv Dave, Yazan Masannat, Tahir Masudi, Senthurun Mylvaganam, (unknown), Nicola Barnes, Sue Down, Chris Holcombe, Shelley Potter, Matthew D. Gardiner, Anthony Maxwell, (unknown), Amtul Sami, Cliona Kirwan, James Harvey	5
7	Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia 2022 ·BMJ Open ·Karen Clements, David Dodwell, Bridget Hilton, (unknown), Sarah E. Pinder, Matthew Wallis, Anthony Maxwell, Olive Kearins, Mark Sibbering, Abeer M. Shaaban, Cliona Kirwan, Nisha Sharma, Hilary Stobart, (unknown), Janet Litherland, Senthurun Mylvaganam, Elena Provenzano, Elinor J. Sawyer, Alastair M. Thompson	3
8	Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration 2022 ·Journal of Thrombosis and Haemostasis ·Sukhraj Pal Singh Dhami, (unknown), Claire Comerford, (unknown), Brenton Cavanagh, (unknown), Cliona Kirwan, (unknown), Ingmar Schoen, James S. O’Donnell, Jamie M. O’Sullivan	34
9	The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making 2022 ·European Journal of Surgical Oncology ·Jenna Morgan, Vinton W.T. Cheng, Peter Barry, Ellen Copson, Ramsey Cutress, Rajiv Dave, Beatrix Elsberger, Patricia Fairbrother, (unknown), Brian Hogan, Kieran Horgan, Cliona Kirwan, Stuart McIntosh, Rachel O’Connell, Neill Patani, Shelley Potter, Tim Rattay, (unknown), Lynda Wyld, Baek Kim	7
10	Innovations for the future of breast surgery 2021 ·British journal of surgery ·Raghavan Vidya, Daniel Leff, (unknown), Stuart McIntosh, Edward St John, Cliona Kirwan, László Romics, Ramsey Cutress, Shelley Potter, Amtul R. Carmichael, (unknown), Rachel O’Connell, Patricia Fairbrother, Deborah Fenlon, John R. Benson, Chris Holcombe	14
11	Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study). 2021 ·Apollo (University of Cambridge) ·(unknown), Karoline Freeman, Karen Clements, Bridget Hilton, (unknown), Olive Kearins, Nigel Stallard, Matthew Wallis, Nisha Sharma, Cliona Kirwan, Sarah E. Pinder, Elena Provenzano, Abeer M. Shaaban, Hilary Stobart, (unknown), Alastair M. Thompson, Sian Taylor‐Phillips	4
12	Patient and public priorities for breast cancer research: a qualitative study in the UK 2021 ·BMJ Open ·George Boundouki, Rebecca L. Wilson, (unknown), Julia Henderson, Laura Ballance, Julie Wray, (unknown), Ibrahim Ibrahim, James Harvey, Cliona Kirwan	9
13	Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design 2021 ·Trials ·Indrani Bhattacharya, Joanne Haviland, Lesley Turner, Hilary Stobart, (unknown), Liba Stones, Anna M. Kirby, Cliona Kirwan, Charlotte E. Coles, Judith M. Bliss, (unknown)	6
14	Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion 2020 ·Cancer Medicine ·(unknown), Nigel Bundred, Göran Landberg, Susan Pritchard, (unknown), Sarah Leigh Nicholson, (unknown), (unknown), (unknown), Cliona Kirwan	23
15	Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial 2020 ·The Lancet Oncology ·Ian Smith, J.F.R. Robertson, Lucy Kilburn, Maggie Wilcox, Abigail Evans, Chris Holcombe, Kieran Horgan, Cliona Kirwan, Elizabeth Mallon, Mark Sibbering, Anthony Skene, Raghavan Vidya, Maggie C.U. Cheang, Jane Banerji, James P. Morden, Kally Sidhu, Andrew Dodson, Judith M. Bliss, Mitch Dowsett	147
16	Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial 2019 ·Radiotherapy and Oncology ·Indrani Bhattacharya, Joanne Haviland, (unknown), David Eaton, S. Gulliford, Emma Harris, Charlotte E. Coles, Cliona Kirwan, Judith M. Bliss, Anna M. Kirby	9
17	Infection prevention in breast implant surgery – A review of the surgical evidence, guidelines and a checklist 2016 ·European Journal of Surgical Oncology ·(unknown), Ashley Topps, Nicola Barnes, Julia Henderson, S. Hignett, Rebecca L. Teasdale, (unknown), James Harvey, Cliona Kirwan	54
18	IMPORT Trial Management Group. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom. 2015 ·British Journal of Radiology ·Y. Tsang, L. Ciurlionis, Cliona Kirwan, Anna M. Kirby, Imogen Locke, Karen Venables, John Yarnold, Jenny Titley, Judith M. Bliss, Charlotte E. Coles	42
19	Breast cancer biology and risk of venous thromboembolism 2013 ·European Journal of Cancer ·Alex J Walker, Jay West, Tim Card, Colin Crooks, Cliona Kirwan, Matthew J. Grainge	1
20	Tumour bed clip localisation for targeted breast radiotherapy: Compliance is proportional to trial-related research activity 2013 ·European Journal of Surgical Oncology ·Cliona Kirwan, Wail Al Sarakbi, J. Loncaster, H.-Y. Chan, A.M. Thompson, Gordon Wishart	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact